Docetaxel - Carboplatin as Second Line Treatment in Patients With Small Cell Lung Cancer (DOCAR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Jeroen Bosch Ziekenhuis.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Jeroen Bosch Ziekenhuis
ClinicalTrials.gov Identifier:
NCT00686985
First received: May 27, 2008
Last updated: May 29, 2008
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2010
  Estimated Primary Completion Date: No date given